3 Pharma Ingredients Maker, Commodity Exchange and Transmission Towers Maker Stocks With a Strong Future Roadmap: Divi’s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering
- November 5, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Divi’s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering: ROE of 15.3% to 46.8% and FY22 to FY26 revenue CAGR of 5.1% to 53.9%. Prices as of 4 Nov 2026.
Quick Answer
The three API maker, commodity exchange and tower stocks to watch are Divi’s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering. Their return on equity ranges from 15.3% to 46.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.1% to 53.9%. Multi Commodity Exchange of India leads on both return on equity at 46.8% and revenue growth at 53.9% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.
API maker, commodity exchange and tower stocks give investors a way to track businesses that sit close to everyday demand in India. Divi’s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering cover an active pharmaceutical ingredients maker, a commodity derivatives exchange and a transmission towers maker.
This list covers three API maker, commodity exchange and tower stocks with complete current figures: Divi’s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are API Maker, Commodity Exchange and Tower Stocks?
API maker, commodity exchange and tower stocks are listed companies that make active ingredients and intermediates for global drug makers, run a leading commodity derivatives exchange, and build transmission line towers and monopoles for power utilities. Their earnings depend on global drug orders, trading activity and grid projects.
API Maker, Commodity Exchange and Tower Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Divi’s Laboratories | 10,037.5 | 241,311 | 82.5 | 36.0 | 15.3 | 0.00 |
| Multi Commodity Exchange of India | 3,315 | 81,189 | 52.7 | 41.8 | 46.8 | 0.00 |
| Karamtara Engineering | 383 | 11,949 | 52.2 | 43.9 | 18.8 | 0.91 |
On valuation, all three trade at a P/E above their industry P/E, which reflects the growth the market already expects from them. Readers comparing API maker, commodity exchange and tower stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do API Maker, Commodity Exchange and Tower Stocks Have a Strong Roadmap in India?
API maker, commodity exchange and tower stocks have a strong roadmap in India because rising global pharma outsourcing, growing hedging and trading activity and large grid investment keep widening the market for these companies.
- Pharma ingredients. Global drug makers need dependable suppliers.
- Commodity exchange. Traders and hedgers use contracts.
- Transmission towers. Grid projects need new lines.
Why Divi’s Laboratories Features Among These API Maker, Commodity Exchange and Tower Stocks
Among the API maker, commodity exchange and tower stocks on this list, Divi’s Laboratories is a Hyderabad-based maker of active pharmaceutical ingredients, intermediates and custom synthesis products, serving large global pharma companies from large-scale manufacturing sites.
The company has a return on equity of 15.3%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 241,311 crore. The stock trades at a P/E of 82.5, above the industry P/E of 36.0.
Revenue rose from Rs 9,074 crore in FY22 to Rs 11,067 crore in FY26, a compound annual growth rate of 5.1%. Net profit grew from Rs 1,823 crore in FY23 to Rs 2,568 crore in FY26, which works out to a compound annual growth rate of 12.1%. In the June 2026 quarter, revenue grew 24.3% year on year to Rs 3,144 crore, while net profit rose 65.5% to Rs 902 crore.
Roadmap: The company is a key supplier of ingredients for several widely used generics and has long-standing contract manufacturing relationships with global innovators. Capacity additions at its sites and a growing custom synthesis pipeline support future volumes.
What to watch: Check the order flow in custom synthesis and the commissioning of new capacity.
Why Multi Commodity Exchange of India Features Among These API Maker, Commodity Exchange and Tower Stocks
Among the pharma, market and power shares on this list, Multi Commodity Exchange of India, known as MCX, is the country’s leading commodity derivatives exchange, offering futures and options in bullion, base metals, energy and agricultural products.
Revenue rose from Rs 433 crore in FY22 to Rs 2,429 crore in FY26, a compound annual growth rate of 53.9%. Net profit grew from Rs 143 crore in FY22 to Rs 1,332 crore in FY26, which works out to a compound annual growth rate of 74.5%.
The company has a return on equity of 46.8%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 81,189 crore. The stock trades at a P/E of 52.7, above the industry P/E of 41.8.
Roadmap: Volatility in gold, silver and crude oil and the growth of options trading lift volumes on the exchange. A new trading platform and a wider product range, including more contracts, support its roadmap.
What to watch: Follow trading volumes, since earnings track market activity and regulatory changes.
Why Karamtara Engineering Features Among These API Maker, Commodity Exchange and Tower Stocks
Among the three companies on this list, Karamtara Engineering makes transmission line towers, monopoles and structures for power utilities, and also supplies solar mounting structures.
Revenue rose from Rs 1,247 crore in FY22 to Rs 4,316 crore in FY26, a compound annual growth rate of 36.4%. Net profit grew from Rs 103 crore in FY24 to Rs 229 crore in FY26, which works out to a compound annual growth rate of 49.3%.
The company has a return on equity of 18.8%, a debt to equity ratio of 0.91 and a market capitalisation of Rs 11,949 crore. The stock trades at a P/E of 52.2, above the industry P/E of 43.9.
Roadmap: Large transmission corridors and renewable energy connections create sustained demand for towers and structures. The company is widening its capacity and its customer base, which includes state utilities and power grid developers.
What to watch: Keep an eye on order execution timelines and steel price movements.
Divi’s Laboratories vs Multi Commodity Exchange of India vs Karamtara Engineering on Key Financials
The table below sets the three API maker, commodity exchange and tower stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Divi’s Laboratories | 9,074 | 11,067 | 5.1% | 2,568 | 23.2% |
| Multi Commodity Exchange of India | 433 | 2,429 | 53.9% | 1,332 | 54.8% |
| Karamtara Engineering | 1,247 | 4,316 | 36.4% | 229 | 5.3% |
Multi Commodity Exchange of India posts the highest return on equity in this group at 46.8%. Divi’s Laboratories has the largest FY26 revenue at Rs 11,067 crore, and Multi Commodity Exchange of India shows the fastest revenue growth with a 53.9% compound annual rate. A useful habit with API maker, commodity exchange and tower stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in API Maker, Commodity Exchange and Tower Stocks
Every theme carries risks that deserve a check before any decision. For these API maker, commodity exchange and tower stocks, the main points are: Long-term pharma, market and power shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Regulatory approvals. Plant inspections and approvals can affect supplies.
- Order timing. Project awards can shift between periods.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter API maker, commodity exchange and tower stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on API Maker, Commodity Exchange and Tower Stocks
API maker, commodity exchange and tower stocks work best when investors track growth, valuation and return on equity side by side. Divi’s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering each have a clear plan to grow. Based on the 4 November 2026 close, Divi’s Laboratories trades at Rs 10,037.5, Multi Commodity Exchange of India at Rs 3,315 and Karamtara Engineering at Rs 383. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these API maker, commodity exchange and tower stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track API maker, commodity exchange and tower stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are API maker, commodity exchange and tower stocks?
Ans. API maker, commodity exchange and tower stocks are listed companies that make active ingredients and intermediates for global drug makers, run a leading commodity derivatives exchange, and build transmission line towers and monopoles for power utilities. Their earnings depend on global drug orders, trading activity and grid projects. This list looks at three of them, Divi’s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.
Which API maker, commodity exchange and tower stocks are covered in this list?
Ans. This list covers Divi’s Laboratories, Multi Commodity Exchange of India and Karamtara Engineering. Based on the 4 November 2026 close, Divi’s Laboratories traded at Rs 10,037.5, Multi Commodity Exchange of India at Rs 3,315 and Karamtara Engineering at Rs 383. Their return on equity ranges from 15.3% to 46.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.1% to 53.9%.
Why do API maker, commodity exchange and tower stocks have a strong future roadmap in India?
Ans. API maker, commodity exchange and tower stocks have a strong roadmap in India because rising global pharma outsourcing, growing hedging and trading activity and large grid investment keep widening the market for these companies. The main drivers are as follows. Pharma ingredients. Global drug makers need dependable suppliers. Commodity exchange. Traders and hedgers use contracts. Transmission towers. Grid projects need new lines. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Divi’s Laboratories performed financially?
Ans. Revenue rose from Rs 9,074 crore in FY22 to Rs 11,067 crore in FY26, a compound annual growth rate of 5.1%. Net profit grew from Rs 1,823 crore in FY23 to Rs 2,568 crore in FY26, which works out to a compound annual growth rate of 12.1%. In the June 2026 quarter, revenue grew 24.3% year on year to Rs 3,144 crore, while net profit rose 65.5% to Rs 902 crore. The company has a return on equity of 15.3%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 241,311 crore. The stock trades at a P/E of 82.5, above the industry P/E of 36.0. Looking ahead, the company is a key supplier of ingredients for several widely used generics and has long-standing contract manufacturing relationships with global innovators. Capacity additions at its sites and a growing custom synthesis pipeline support future volumes.
How has Multi Commodity Exchange of India performed financially?
Ans. Revenue rose from Rs 433 crore in FY22 to Rs 2,429 crore in FY26, a compound annual growth rate of 53.9%. Net profit grew from Rs 143 crore in FY22 to Rs 1,332 crore in FY26, which works out to a compound annual growth rate of 74.5%. The company has a return on equity of 46.8%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 81,189 crore. The stock trades at a P/E of 52.7, above the industry P/E of 41.8. Looking ahead, volatility in gold, silver and crude oil and the growth of options trading lift volumes on the exchange. A new trading platform and a wider product range, including more contracts, support its roadmap.
How has Karamtara Engineering performed financially?
Ans. Revenue rose from Rs 1,247 crore in FY22 to Rs 4,316 crore in FY26, a compound annual growth rate of 36.4%. Net profit grew from Rs 103 crore in FY24 to Rs 229 crore in FY26, which works out to a compound annual growth rate of 49.3%. The company has a return on equity of 18.8%, a debt to equity ratio of 0.91 and a market capitalisation of Rs 11,949 crore. The stock trades at a P/E of 52.2, above the industry P/E of 43.9. Looking ahead, large transmission corridors and renewable energy connections create sustained demand for towers and structures. The company is widening its capacity and its customer base, which includes state utilities and power grid developers.
What risks should investors check before buying API maker, commodity exchange and tower stocks?
Ans. Investors should check a few risks before buying API maker, commodity exchange and tower stocks. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Project awards can shift between periods. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of API maker, commodity exchange and tower stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
